Tina Esfandiary
Overview
Explore the profile of Tina Esfandiary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rabinowitz M, Esfandiary T, Cheaib J, Patel S, Alam R, Metcalf M, et al.
Eur Urol Open Sci
. 2022 Nov;
43:28-34.
PMID: 36353070
Background: Renal cell carcinoma (RCC) can exhibit a unique vascular tropism that enables tumor thrombus extension into the inferior vena cava (IVC). While most RCC subtypes that form tumor thrombi...
2.
Goeddel L, Murphy Z, Owodunni O, Esfandiary T, Campbell D, Shay J, et al.
Ann Surg
. 2022 Sep;
278(2):e226-e233.
PMID: 36124773
Importance: Preoperative frailty has been consistently associated with death, severe complications, and loss of independence (LOI) after surgery. LOI is an important patient-centered outcome, but it is unclear which domains...
3.
Shou B, Aravind P, Ong C, Alejo D, Canner J, Etchill E, et al.
Ann Thorac Surg
. 2022 Aug;
115(1):232-239.
PMID: 35952856
Background: Reexploration after cardiac surgery, most frequently for bleeding, is a quality metric used to assess surgical performance. This may cause surgeons to delay return to the operating room in...
4.
Goeddel L, Erlinger S, Murphy Z, Tang O, Bergmann J, Moeller S, et al.
Anesth Analg
. 2022 Apr;
135(3):605-616.
PMID: 35467553
Background: Acute kidney injury (AKI) after major noncardiac surgery is commonly attributed to cardiovascular dysfunction. Identifying novel associations between preoperative cardiovascular markers and kidney injury may guide risk stratification and...
5.
Reker D, Rybakova Y, Kirtane A, Cao R, Yang J, Navamajiti N, et al.
Nat Nanotechnol
. 2021 Mar;
16(6):725-733.
PMID: 33767382
Nanoformulations of therapeutic drugs are transforming our ability to effectively deliver and treat a myriad of conditions. Often, however, they are complex to produce and exhibit low drug loading, except...
6.
Esfandiary T, Park J, Alexanderson H, Regardt M, Needham M, de Groot I, et al.
Semin Arthritis Rheum
. 2020 Sep;
50(5):943-948.
PMID: 32906029
Objective: To investigate the content validity of several patient-reported outcome measures (PROMs) in patients with idiopathic inflammatory myopathies (IIM). Methods: Seven individual PROM instruments were selected by the Outcome Measures...
7.
von Erlach T, Saxton S, Shi Y, Minahan D, Reker D, Javid F, et al.
Nat Biomed Eng
. 2020 Apr;
4(5):544-559.
PMID: 32341538
Monolayers of cancer-derived cell lines are widely used in the modelling of the gastrointestinal (GI) absorption of drugs and in oral drug development. However, they do not generally predict drug...
8.
Raman R, Hua T, Gwynne D, Collins J, Tamang S, Zhou J, et al.
Sci Adv
. 2020 Feb;
6(3):eaay0065.
PMID: 32010768
Triggerable materials capable of being degraded by selective stimuli stand to transform our capacity to precisely control biomedical device activity and performance while reducing the need for invasive interventions. Here,...